Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice

Neurobiology of Aging

Volumn 28, Issue 9, 2007, Pages 1297-1306

  Knobloch, Marlen ^a   Konietzko, Uwe ^a   Krebs, Danielle C ^a   Nitsch, Roger M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

A ; Alzheimer's disease; Behavior; Blood brain barrier; Intracellular; Learning and memory

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

AGE; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; ANALYSIS OF VARIANCE; ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; EXPLORATORY BEHAVIOR; GENETICS; HUMAN; MASS SPECTROMETRY; MAZE TEST; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; MUTATION; NEUROLOGIC EXAMINATION; PATHOLOGY; PHYSIOLOGY; ROTAROD TEST; SENILE PLAQUE; TRANSGENIC MOUSE;

AGE FACTORS; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; COGNITION DISORDERS; EXPLORATORY BEHAVIOR; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NEUROLOGIC EXAMINATION; ROTAROD PERFORMANCE TEST; SENILE PLAQUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34447564164     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.06.019     Document Type: Article

References (38)

1. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., and Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 3 Pt 1 (1992) 631-639
2. Billings L.M., Oddo S., Green K.N., McGaugh J.L., and Laferla F.M. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45 5 (2005) 675-688
3. Borchelt D.R., Davis J., Fischer M., Lee M.K., Slunt H.H., Ratovitsky T., et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13 6 (1996) 159-163
4. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2 3 (1999) 271-276
5. Cheng I.H., Palop J.J., Esposito L.A., Bien-Ly N., Yan F., and Mucke L. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 10 11 (2004) 1190-1192
6. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8 1 (2005) 79-84
7. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835 1 (1999) 18-26
8. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277 35 (2002) 32046-32053
9. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 3 (2004) 333-344
10. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., et al. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100 18 (2003) 10417-10422
11. Gotz J., Chen F., van Dorpe J., and Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293 5534 (2001) 1491-1495
12. Gouras G.K., Almeida C.G., and Takahashi R.H. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging (2005)
13. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156 1 (2000) 15-20
14. Haass C., and Steiner H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders?. Nat Neurosci 4 9 (2001) 859-860
15. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 5054 (1992) 184-185
16. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38 28 (1999) 8972-8980
17. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W., van Harskamp F., et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1 3 (1992) 218-221
18. Herzig M.C., Winkler D.T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S.D., et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7 9 (2004) 954-960
19. Hock C., Konietzko U., Streffer J.R., Tracy J., Signorell A., Muller-Tillmanns B., et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38 4 (2003) 547-554
20. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29 3 (1999) 177-185
21. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 5284 (1996) 99-102
22. Hyman B.T., Marzloff K., and Arriagada P.V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 52 6 (1993) 594-600
23. Kamino K., Orr H.T., Payami H., Wijsman E.M., Alonso M.E., Pulst S.M., et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51 5 (1992) 998-1014
24. Kumar-Singh S., Cras P., Wang R., Kros J.M., van Swieten J., Lubke U., et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 161 2 (2002) 507-520
25. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95 11 (1998) 6448-6453
26. Lashuel H.A., Hartley D.M., Petre B.M., Wall J.S., Simon M.N., Walz T., et al. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol 332 4 (2003) 795-808
27. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 7082 (2006) 352-357
28. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., van Duinen S.G., et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248 4959 (1990) 1124-1126
29. Lord A., Kalimo H., Eckman C., Zhang X.Q., Lannfelt L., and Nilsson L.N. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol Aging 27 1 (2006) 67-77
30. Monro O.R., Mackic J.B., Yamada S., Segal M.B., Ghiso J., Maurer C., et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 23 3 (2002) 405-412
31. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1 5 (1992) 345-347
32. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4 9 (2001) 887-893
33. Richardson J.C., Kendal C.E., Anderson R., Priest F., Gower E., Soden P., et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience 122 1 (2003) 213-228
34. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275 5300 (1997) 630-631
35. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 6880 (2002) 535-539
36. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J Neurochem 91 3 (2004) 513-520
37. Wolfer D.P., Litvin O., Morf S., Nitsch R.M., Lipp H.P., and Wurbel H. Laboratory animal welfare: cage enrichment and mouse behaviour. Nature 432 7019 (2004) 821-822
38. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28 4 (2005) 202-208